Tiziana Life Sciences Plans to Raise $3.3 Million in London IPO

... retain about 75 percent of the company, he said. Tiziana is founded on research at the European Cancer Stem Cell Research Institute in Cardiff, Wales. Scientists there have identified the BCL3 gene as a drug target to halt the spread of metastatic ...

http://ift.tt/1f9izdF